Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-02-11
1989-03-21
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
048143391
ABSTRACT:
Hydroypyridine analogs, Dihydropyridine analogs, Trihydropyridine analogs, Hydropurine analogs, Dihydropurine analogs, Trihydropurine analogs, N,N,N,'-trimethyl-N'-(2-hydroxy-3-methyl-1,3-propanediamine analogs, 1-methyl-3-[N-(4-iodophenyl)-carbamoyl]-1,4-dihydropyridine analogs, that are lipid-soluble with the specific electron charge density and therefore useful for the administration of several compounds that need to penetrate the blood-Brain capilliary barrier. Once inside the brain these compounds under go NAD-NADH reduction thereby providing for a brain serum retention. These compounds having been modified herein to deliver various compounds, some of which are those that are progressively absent during the course of a disease called Alzheimer's Disease.
REFERENCES:
patent: 3016378 (1962-01-01), Roch
patent: 3651045 (1972-03-01), Haskell et al.
patent: 3825541 (1974-07-01), Vince
patent: 3920823 (1975-11-01), Meyer et al.
patent: 4011329 (1977-03-01), Fake
patent: 4048432 (1977-09-01), Baker
patent: 4055717 (1977-10-01), Baker et al.
patent: 4055718 (1977-10-01), Baker
patent: 4138562 (1979-02-01), Vince
patent: 4268672 (1981-05-01), Vince
patent: 4271170 (1981-06-01), Tanouchi et al.
patent: 4317828 (1982-03-01), Tanouchi et al.
patent: 4321376 (1982-03-01), Otani et al.
patent: 4338310 (1982-07-01), Vince
patent: 4362729 (1982-12-01), Vince
patent: 4370334 (1983-01-01), Sato
patent: 4383114 (1983-05-01), Vince
patent: 4450165 (1984-05-01), Araki et al.
patent: 4624852 (1986-11-01), Wurtman
Chem. Abst.-88-6668 N (1978).
Chem. Abst.-89-41983g (1978).
"Advancing Frontiers in Alzheimer's Disease Research", edited by George G. Glenner and Richard J. Wurtman-1st ed., Austin-University of Texas Press, 1987, pp. 1-9.
"Intrahippocampal Septal Grafts Ameliorate Learning Impairments in Aged Rats", Science, vol. 225, pp. 533-535, Gage et al. (8/84).
"Alzheimer's Disease: Cell-Specific Pathology Isolates the Hippocampal Formation", Science, vol. 225, pp. 1168-1170, Hyman et al.
"Turnover of Inositol Phospholipids and Signal Transduction", Science, Sep. 21, 1984, pp. 1365-1370, Nishizuka.
"Neuronal Phosphoproteins: Physiologic and Clinical Implications", Science, Sep. 21, 1984, pp. 1357-1364, Nestler et al.
"Effects of Dietary Choline on Phospholipid Metabolism in the Brain," Ohio State University, pp. 237-245, Pendley, II et al.
"Are the Phospholipids in Cholinergic Neurons a Source of Choline for Acetylcholine Synthesis?", Boston University School of Medicin, pp. 229-235, Blusztajn et al. (1985).
"Phospholipase Activities in Rat Brain Areas During Aging", Universita di Perugia, pp. 155-161, Gaiti et al.
"Metabolic and Functional Aspects of Neural Membrane Phospholipids", Ohio State University, pp. 341-343, Farooqui et al.
"Phosphatidylinositol:myo-Inositol Exchange Activity in Intact Nerve Endings: Substrate and Cofactor Dependence, Nucleotide Specificity, and Effect on Synaptosomal Handling of myo-Inositol", Chil. Hosp. of Philadelphia, Berry et al.
"Phospholipids are Pharmacological Tools in the Aging Brain", Fidia Research Laboratories, pp. 11-17, Calderini et al.
"Evaluation of the Brain-Specific Delivery of Radiodinated (Iodophenyl) alkyl-Substituted Amines Coupled to a Dihydropyridine Carrier", J. Med. Chem., 1985, 1574-1580, Tedjmulia et al.
"Effects of .DELTA.9-Tetrahydrocannabinol on Regional Brain Acetylcholine", Univ. of Mich., pp. 673-678, Domino et al.
Advanced Biologics, Inc.
Friedman Stanley J.
LandOfFree
Treatment for Alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment for Alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for Alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-477200